These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3883848)

  • 1. Protamine: a review of its toxicity.
    Horrow JC
    Anesth Analg; 1985 Mar; 64(3):348-61. PubMed ID: 3883848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
    Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
    Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamics of protamine administration. Comparison of right atrial, left atrial, and aortic injections.
    Katz NM; Kim YD; Siegelman R; Ved SA; Ahmed SW; Wallace RB
    J Thorac Cardiovasc Surg; 1987 Dec; 94(6):881-6. PubMed ID: 3682857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of protamine sulfate in man.
    Shapira N; Schaff HV; Piehler JM; White RD; Still JC; Pluth JR
    J Thorac Cardiovasc Surg; 1982 Oct; 84(4):505-14. PubMed ID: 7121041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
    Rogers K; Milne B; Salerno TA
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
    Stefaniszyn HJ; Novick RJ; Salerno TA
    J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
    Fiser WP; Fewell JE; Hill DE; Barnes RW; Read RC
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic changes during protamine administration.
    Michaels IA; Barash PG
    Anesth Analg; 1983 Sep; 62(9):831-5. PubMed ID: 6603799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic changes after the administration of protamine.
    Casthely PA; Goodman K; Fyman PN; Abrams LM; Aaron D
    Anesth Analg; 1986 Jan; 65(1):78-80. PubMed ID: 3940472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody formation after drug administration during cardiac surgery: parameters for aprotinin use.
    Levy JH
    J Heart Lung Transplant; 1993; 12(1 Pt 1):S26-33. PubMed ID: 7680234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions to protamine.
    Horrow JC
    Int Anesthesiol Clin; 1985; 23(3):133-44. PubMed ID: 4030121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
    Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
    Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of patients at risk for protamine reactions.
    Levy JH; Schwieger IM; Zaidan JR; Faraj BA; Weintraub WS
    J Thorac Cardiovasc Surg; 1989 Aug; 98(2):200-4. PubMed ID: 2755152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of clemastine--H1 histamine receptor blocker in the prevention of haemodynamic disorders after protamine sulfate administration in patients subjected to coronary artery bypass grafting in extracorporeal circulation.
    Lango R; MroziĊ„ski P; Wujtewicz M; Suchorzewska J; Rogowski J; Narkiewicz M; Siebert J
    Med Sci Monit; 2000; 6(4):769-75. PubMed ID: 11208407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-mediated reductions of the toxic effects of protamine sulfate on rabbit myocardium.
    Wakefield TW; Wrobleski SK; Nichol BJ; Kadell AM; Stanley JC
    J Vasc Surg; 1992 Jul; 16(1):47-53. PubMed ID: 1619724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions.
    Montalescot G; Kreil E; Lynch K; Greene EM; Torres A; Carvalho A; Fitzgibbon C; Robinson DR; Lowenstein E; Zapol WM
    J Appl Physiol (1985); 1989 May; 66(5):2344-50. PubMed ID: 2745299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analogues.
    Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Fazzalari A; Nichol BJ; Vanderkooi T; Stanley JC
    J Surg Res; 1994 Jun; 56(6):586-93. PubMed ID: 8015315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The total artificial heart. A better model to study the hemodynamic effect of protamine.
    De Paulis R; Mohammad SF; Riebman JB; Deleuze P; Morea M; Olsen DB
    ASAIO Trans; 1987; 33(3):217-21. PubMed ID: 3675947
    [No Abstract]   [Full Text] [Related]  

  • 19. Protamine-induced thrombocytopenia and leukopenia.
    Al-Mondhiry H; Pierce WS; Basarab RM
    Thromb Haemost; 1985 Feb; 53(1):60-4. PubMed ID: 3873119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin, protamine, and ionized calcium in vitro and in vivo.
    Goto H; Kushihashi T; Benson KT; Kato H; Fox DK; Arakawa K
    Anesth Analg; 1985 Nov; 64(11):1081-4. PubMed ID: 3931505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.